Apogee Therapeutics, Inc.
APGE
$39.94
$1.614.20%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 520.65M | 526.05M | 676.23M | 816.20M | 395.46M |
Total Receivables | 4.70M | 4.77M | -- | -- | 1.21M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.62M | 3.27M | 2.24M | 1.69M | 1.74M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.74M | 396.00K | 3.39M | 2.72M | -- |
Total Current Assets | 529.71M | 534.48M | 681.85M | 820.61M | 398.41M |
|
|||||
Total Current Assets | 529.71M | 534.48M | 681.85M | 820.61M | 398.41M |
Net Property, Plant & Equipment | 13.32M | 13.54M | 4.94M | 2.65M | 2.59M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 498.00K | 514.00K | 468.00K | 401.00K | 401.00K |
Total Assets | 753.95M | 776.29M | 800.66M | 823.66M | 401.40M |
|
|||||
Total Accounts Payable | 1.07M | 2.22M | 5.53M | 4.30M | 2.14M |
Total Accrued Expenses | 24.26M | 27.53M | 17.41M | 16.11M | 17.31M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.23M | 2.87M | 1.68M | 1.14M | 1.10M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 28.56M | 32.61M | 24.62M | 21.55M | 20.56M |
|
|||||
Total Current Liabilities | 28.56M | 32.61M | 24.62M | 21.55M | 20.56M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 8.60M | 9.27M | 2.40M | 630.00K | 933.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 37.16M | 41.88M | 27.02M | 22.18M | 21.49M |
|
|||||
Common Stock & APIC | 1.02B | 969.83M | 963.61M | 957.52M | 503.35M |
Retained Earnings | -305.92M | -238.70M | -189.68M | -155.86M | -123.77M |
Treasury Stock & Other | 915.00K | 3.27M | -289.00K | -177.00K | 329.00K |
Total Common Equity | 716.79M | 734.40M | 773.64M | 801.48M | 379.91M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 716.79M | 734.40M | 773.64M | 801.48M | 379.91M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 716.79M | 734.40M | 773.64M | 801.48M | 379.91M |
|